Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Extends Offer for Beckman Coulter for Third Time

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher on Tuesday extended for a third time its cash tender offer for Beckman Coulter.

The offer to acquire all outstanding shares of Beckman Coulter is now set to expire on June 24, 5 p.m., New York City time. It had been scheduled to expire at midnight June 6.

The company said that it anticipates regulatory approval of the $6.8 billion deal from the European Commission on or about June 16, and to close on it before the end of June. As of 4 p.m. on May 31, more than 25 million shares of Beckman Coulter's stock had been validly tendered and not withdrawn, Danaher said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.